New Aspects of Ultrasound-Mediated Targeted Delivery and Therapy for Cancer

被引:33
作者
Tian, Yuhang [1 ]
Liu, Zhao [1 ]
Tan, Haoyan [1 ]
Hou, Jiahui [1 ]
Wen, Xin [1 ]
Yang, Fan [1 ]
Cheng, Wen [1 ]
机构
[1] Harbin Med Univ, Canc Hosp, Dept Ultrasound, 150 Haping Rd, Harbin 150080, Peoples R China
来源
INTERNATIONAL JOURNAL OF NANOMEDICINE | 2020年 / 15卷
基金
中国国家自然科学基金;
关键词
ultrasound; targeted delivery; immunotherapy; gene therapy; LOADED LIPID MICROBUBBLES; DRUG-DELIVERY; FOCUSED ULTRASOUND; CONTRAST AGENTS; GENE-THERAPY; RADIATION-FORCE; GRAPHENE OXIDE; BREAST-CANCER; SENSITIVE LIPOSOMES; COMBINATION THERAPY;
D O I
10.2147/IJN.S201208
中图分类号
TB3 [工程材料学];
学科分类号
0805 ; 080502 ;
摘要
Ultrasound-mediated targeted delivery (UMTD), a novel delivery modality of therapeutic materials based on ultrasound, shows great potential in biomedical applications. By coupling ultrasound contrast agents with therapeutic materials, UMTD combines the advantages of ultrasound imaging and carrier, which benefit deep tissue penetration and high concentration aggregation. In this paper we introduced recent advances in ultrasound contrast agents and applications in tumor therapy. Ultrasound contrast agents were categorized by their functions, mainly including thermosensitive, pH-sensitive and photosensitive ultrasound contrast agents. The various applications of UMTD in tumor treatment were summarized as follows: drug therapy, transfection of anti-oncogene, RNA interference, vaccine immunotherapy, monoclonal antibody immunotherapy, adoptive cellular immunotherapy, cytokine immunotherapy, and so on. In the end, we elaborated on the current challenges and provided perspectives of UMTD for clinical applications.
引用
收藏
页码:401 / 418
页数:18
相关论文
共 148 条
  • [1] Hypoxia-Induced Cytotoxic Drug Resistance in Osteosarcoma Is Independent of HIF-1Alpha
    Adamski, Jennifer
    Price, Andrew
    Dive, Caroline
    Makin, Guy
    [J]. PLOS ONE, 2013, 8 (06):
  • [2] Cancer immunotherapies, their safety and toxicity
    Alatrash, Gheath
    Jakher, Haroon
    Stafford, Patricia D.
    Mittendorf, Elizabeth A.
    [J]. EXPERT OPINION ON DRUG SAFETY, 2013, 12 (05) : 631 - 645
  • [3] Early treatment of HER2-amplified brain tumors with targeted NK-92 cells and focused ultrasound improves survival
    Alkins, Ryan
    Burgess, Alison
    Kerbel, Robert
    Wels, Winfried S.
    Hynynen, Kullervo
    [J]. NEURO-ONCOLOGY, 2016, 18 (07) : 974 - 981
  • [4] Focused Ultrasound Delivers Targeted Immune Cells to Metastatic Brain Tumors
    Alkins, Ryan
    Burgess, Alison
    Ganguly, Milan
    Francia, Giulio
    Kerbel, Robert
    Wels, Winfried S.
    Hynynen, Kullervo
    [J]. CANCER RESEARCH, 2013, 73 (06) : 1892 - 1899
  • [5] Opinion - Survivin, cancer networks and pathway-directed drug discovery
    Altieri, Dario C.
    [J]. NATURE REVIEWS CANCER, 2008, 8 (01) : 61 - 70
  • [6] Modulation of membrane traffic by mechanical stimuli
    Apodaca, G
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2002, 282 (02) : F179 - F190
  • [7] MicroRNA-122 Inhibits Tumorigenic Properties of Hepatocellular Carcinoma Cells and Sensitizes These Cells to Sorafenib
    Bai, Shoumei
    Nasser, Mohd W.
    Wang, Bo
    Hsu, Shu-Hao
    Datta, Jharna
    Kutay, Huban
    Yadav, Arti
    Nuovo, Gerard
    Kumar, Pawan
    Ghoshal, Kalpana
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2009, 284 (46) : 32015 - 32027
  • [8] From IL-2 to IL-37: the expanding spectrum of anti-inflammatory cytokines
    Banchereau, Jacques
    Pascual, Virginia
    O'Garra, Anne
    [J]. NATURE IMMUNOLOGY, 2012, 13 (10) : 925 - 931
  • [9] miRNA control of tumor cell invasion and metastasis
    Baranwal, Somesh
    Alahari, Suresh K.
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2010, 126 (06) : 1283 - 1290
  • [10] Boucher Y, 1996, CANCER RES, V56, P4264